Phagocytosis and NOX2 in Liver Fibrogenesis

Project: Research project

Description

DESCRIPTION (provided by applicant): Liver fibrogenesis is a complex wound-healing process elicited by various chronic toxic stimuli. Hepatocyte apoptosis is a main feature of chronic inflammation in the liver, and recently we have demonstrated a direct link between hepatocyte apoptosis and fibrogenic activity in the liver. At the center of liver fibrogenesis are the hepatic stellate cells, which by phagocytosing apoptotic bodies of hepatocytes induce fibrogenic signaling pathways and production of extracellular matrix. Activation of the NADPH oxidase (NOX) is a crucial step in the induction of the fibrogenic activity following phagocytosis. Thus, our HYPOTHESIS is that NOX2 activation with superoxide production in HSC is a key event during liver fibrogenesis. To address this hypothesis our SPECIFIC AIMS will be to study the following areas where NOX2 activation may play a key role: 1. NOX2 increases HSC phagocytic activity of HSC 2. Phagocytosis and NOX2 activation induce fibrogenic signaling pathways 3. Phagocytosis and NOX2 activation induce liver fibrogenesis in vivo. The data emanating from this proposal will help define the mechanistic links between hepatocyte apoptosis resulting from chronic liver injury, phagocytosis and NOX2 activation in HSC, and the resulting oxidative damage and fibrogenic response. Furthermore, the proposed studies will yield important data on the early activation of HSC during fibrogenesis which may translate into designing rational therapeutic approaches to prevent progression of fibrosis. PUBLIC HEALTH RELEVANCE: Liver cirrhosis is a leading cause of morbidity and mortality worldwide. Hepatic stellate cell activation with the resulting production of extracellular matrix is a central event in the fibrogenic process;however, the mechanism by which this occurs is not fully understood. We have previously shown that stellate cells phagocytose apoptotic bodies from hepatocytes and this directly induces their fibrogenic activation via activation of the NADPH oxidase (NOX). Here we propose that NOX2 is a key enzyme in liver fibrogenesis and its activation in stellate cells leads to upregulation of profibrogenic genes. Information originating from the successful completion of the proposed experiments has the potential to be developed into strategies to prevent and treat liver fibrosis.
StatusActive
Effective start/end date3/20/106/30/20

Funding

  • National Institutes of Health: $310,759.00
  • National Institutes of Health: $299,341.00
  • National Institutes of Health: $310,199.00
  • National Institutes of Health: $311,479.00
  • National Institutes of Health: $353,250.00
  • National Institutes of Health: $382,500.00
  • National Institutes of Health: $194,375.00

Fingerprint

Phagocytosis
Liver
Hepatocytes
Apoptosis
Cytophagocytosis
Hepatic Stellate Cells
NADPH Oxidase
Advanced Glycosylation End Products
Fibrosis
Extracellular Matrix
Poisons
Superoxides
Wound Healing
Liver Cirrhosis
Inflammation
Wounds and Injuries
Fatty Liver
Up-Regulation

ASJC

  • Medicine(all)